Medicine and Dentistry
Cohort Analysis
80%
Infection
77%
Severe Acute Respiratory Syndrome Coronavirus 2
61%
Cohort Effect
51%
Human Immunodeficiency Virus
48%
Symptom
42%
COVID-19
41%
Prevalence
38%
Immigrant
34%
Tuberculosis Treatment
31%
Retrospective Cohort Study
30%
Humoral Immunity
29%
Lung Tuberculosis
27%
COVID-19 Vaccine
27%
Tuberculosis
26%
Cellular Immunity
26%
Extrapulmonary Tuberculosis
24%
Adverse Event
24%
mRNA Vaccine
24%
Wart Virus Vaccine
24%
Mycobacterium marinum
24%
Cross Sectional Study
24%
Neisseria meningitidis
24%
Pediatrics
24%
Transplantation
24%
Prospective Cohort Study
24%
Virus Nucleocapsid
24%
Biological Marker
24%
Retrospective Study
24%
Patient Characteristics
24%
Men Who Have Sex with Men
24%
Disease
21%
Logistic Regression Analysis
14%
C Reactive Protein
13%
Physician
13%
Laboratory Test
12%
Postural Orthostatic Tachycardia Syndrome
12%
Functional Disease
12%
Charlson Comorbidity Index
12%
Interferon Gamma Release Assay
11%
Study Participant
9%
Interleukin-6
8%
Hazard Ratio
8%
Sequela
8%
Odds Ratio
6%
Patient with Inflammatory Bowel Disease
6%
Rheumatic Disease
6%
Medical Record
6%
Patient Care
6%
Treatment Interruption
6%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
81%
SARS Coronavirus
77%
mRNA Vaccine
72%
Prevalence
62%
Infection
52%
Lung Tuberculosis
48%
Prospective Cohort Study
48%
Retrospective Study
48%
C Reactive Protein
44%
Comorbidity
38%
Disease
36%
Ethanol
32%
Anemia
32%
Symptom
32%
Immunogenicity
32%
Vaccination Policy
26%
Diabetes Mellitus
24%
Tuberculosis
24%
Mycobacterium marinum
24%
Cross-Sectional Study
24%
Adverse Event
24%
Wart Virus Vaccine
24%
Biological Marker
24%
COVID-19 Vaccine
20%
Liver Disease
16%
Patient Registry
16%
Prospective Study
12%
Prednisolone
12%
Postural Orthostatic Tachycardia Syndrome
12%
Functional Disease
12%
RNA Vaccine
12%
Gamma Interferon
11%
Case-Control Study
8%
Chronic Kidney Failure
8%
D Dimer
8%
Rheumatic Disease
6%
Inflammatory Bowel Disease
6%
Symptomatology
6%
Dizziness
6%
Fatigue
6%
Headache
6%
Immunology and Microbiology
Vaccine Efficacy
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Transplant Procedure
72%
Prevalence
55%
Humoral Immunity
42%
COVID-19
42%
Comorbidity
34%
Antibody Response
33%
Adoptive Immunity
30%
Immunogenicity
27%
Spike
25%
Mycobacterium marinum
24%
Human Immunodeficiency Virus
24%
Virus Nucleocapsid
24%
Antibody Blood Level
23%
Breakthrough Infection
21%
Interferon Gamma
17%
Drug Dose Regimen
17%
Immune Response
16%
Blood Plasma
16%
C-Reactive Protein
13%
CD4
13%
Inflammatory Bowel Disease
10%
Rheumatic Disease
10%
Vaccination Policy
9%
Interleukin-6
8%
Monospecific Antibody
7%
Mortality Rate
6%
All Cause Mortality
5%
